References:

• Luis CA, et al. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing
  in the Southeastern US. International Journal of Geriatric Psychiatry, Online issue, October 21st, 2008.
• Lessig S. et al. Examination of the Montreal Cognitive Assessment (MoCA) and MMSE in Parkinson's disease (PD).
  Abstract T-82. Presented at American Neurological Association Meeting, Salt Lake City, Utah, September 24th, 2008.
• K. Waspe, G. Vorobeychik, N. Beauregard Evaluation of Modified Montreal Cognitive assessment in multiple sclerosis:
  a pilot study. Multiple Sclerosis, 2008; 14(supp 1) p. S29. Presented at ECTRIMS meeting, Montreal, September 2008.
• Song S et al. Executive impairment and MoCA performance in mild cognitive impairment and Alzheimer's disease.
  Presented at the International Neuropsychological Society Annual Meeting. Buenos Aires, Argentina.
  July 2-5 2008, p 258.
• Jun-Young Lee et al. Brief Screening for Mild Cognitive Impairment in Elderly Outpatient Clinic: Validation
  of the Korean Version of the Montreal Cognitive Assessment. 2008; J Geriatr Psychiatry Neurol June 2008, 21;2:104-110.
• Boulanger JM et al. A prospective cognitive evaluation in post stroke/TIA patients using the Montreal Cognitive
  Assessment test (MoCA) . Presented at Nice, France. European Stroke Conference, May 2008.
• Johns, EK et al. The effect of education on performance on the Montreal Cognitive Assessment (MoCA): Normative
  data from the community. The Canadian Journal of Geriatrics, 11, 32-73. [Poster presented at the 28th annual meeting
  of the Canadian Geriatrics Society, Montreal, QC, April 2008].
• Ratchford TL, et al. Normative Data for the Montreal Cognitive Assessment (MoCA) in Young Adults. P05.128.
  Presented at the American Academy of Neurology Meeting. April 2008. Neurology 70 March 11, 2008 (Suppl 1) A283.
• Gill DJ et al. The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease.
  Mov Disord. 2008 Mar 31. [Epub ahead of print].
• Ponrathi Athilingam. The Montreal Cognitive Assessment (MoCA): An appropriate tool to assess subtle cognitive
  changes in people with heart failure? Section: "Innovations in Nursing Practice with Older Adults". Presented at the
  ENRS 20th scientific conference. Philadelphia March 27 th, 2008.
• Olson RA et al. Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases.
  0941-4355 (Print) 1433-7339 (Online) Supportive Care in Cancer. Wednesday, March 12, 2008.
• Nestor SM et al. The Montreal Cognitive Assessment: a retrospective pilot study measuring longitudinal cognitive
  change in people with mild cognitive impairment. Presented at the Annual Meeting of the
  Canadian Geriatrics Society, Montreal Canada, Canadian J of Geriatrics Vol 11, Issue
  1, March 2008, p63.
• Koski L. et al. Rasch Analysis reveals qualitative differences in MoCA test performance of
  older persons with Dementia vs Mild cognitive impairment. Presented at the Annual
  Meeting of the Canadian Geriatrics Society, Montreal Canada, Canadian J of Geriatrics
  Vol 11, Issue 1, March 2008, p58.
• Smith M, et al. Case finding of people with cognitive impairment using screening clinics during Alzheimer
  awareness month. Presented at the Annual Meeting of the Canadian Geriatrics Society, Montreal Canada, Canadian J
  of Geriatrics Vol 11, Issue 1, March 2008, p37.
• Johns, EK et al. The Montreal Cognitive Assessment: Normative data in the community. Journal of the International
  Neuropsychological Society, 14(Suppl. 1), i-292. [Poster presented at the 36th annual meeting of the International
  Neuropsychological Society, Waikoloa, Hawaii, February 2008].
• Zadikoff C et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying
  cognitive deficits in Parkinson's disease. Mov Disord. 2008 Jan 30;23(2):297-9.
• Wen HB et al. The application of Montreal cognitive assessment in urban Chinese residents of Beijing.
  Zhonghua Nei Ke Za Zhi. 2008 Jan;47(1):36-9. Chinese.
• Tobinick et al. Rapid cognitive improvement in Alzheimer’s disease following perispinal etanercept administration.
  J of Neuroinflammation January 2008, 5:2 (e-publication, paper publication to come).
• Shiroky et al. Can you have dementia with an MMSE score of 30. Am J of Alzeimers Dis Other Demen
  Oct-Nov 2007;22:5;406-415.
• Chertkow H, Nasreddine Z, Joanette Y, Drolet V, Kirk J, Massoud F, Belleville S, Bergman H. Mild cognitive
  impairment and cognitive impairment, no dementia: Part A, concept and diagnosis Alzheimer's & Dementia:
  The Journal of the Alzheimer's Association October 2007 (Vol. 3, Issue 4, Pages 266-282).
• Howe E. Initial screening of patients for Alzheimer's disease and minimal cognitive impairment. Psychiatry.
  Vol 4(7) Jul 2007, 24-27.
• Holsinger et al. Does this patient have dementia? JAMA, June 6, 2007-Vol 297, No 21;2391-2404.
• Smith T et al. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry.
  2007 May;52(5):329-32.
• Martinić Popović I. et al. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease
  Journal of the Neurological Sciences Volume 257, Issues 1-2, 15 June 2007, Pages 185-193.
• Hachinski et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive
  impairment harmonization standards. Stroke. 2006 Sep;37(9):2220-41. Epub 2006 Aug 17.
• Gauthier et al. Mild cognitive impairment. Lancet. 2006 Apr 15;367(9518):1262-70. Review.
• J. Reban. Montrealsky kognitivni test /MoCA/: přínos k diagnostice predemencí, Česká Geriatrická Revue 2006
  (4):224-229.
• Martinic-Popovic I. et al. Early detection of mild cognitive impairment in patients with cerebrovascular disease. Acta
  Clin Croat 2006;45:77-85.
• Allan L et al. Mild Cognitive Impairment: An Opportunity to Identify Patients at High Risk for
  Progression to Alzheimer's Disease. Clin Ther 2006;28:991-1001.
• Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings
  JL, Chertkow H. The  Montreal Cognitive Assessment (MoCA): A Brief Screening Tool For
  Mild Cognitive Impairment. J Am Geriatr Soc  53:695–699, 2005.
• Nasreddine ZS, Chertkow H, Phillips N, Whitehead V, Collin I, Cummings JL. The Montreal Cognitive
  Assessment (MoCA): a Brief Cognitive Screening Tool for Detection of Mild Cognitive Impairment. Neurology
  Vol 62 No 7 S(5) April 2004 A132. Presented at the American Academy of Neurology Meeting, San Francisco, May 2004.
• Nasreddine ZS, Chertkow H, Phillips N, Whitehead V, Bergman H, Collin I, Cummings JL, Hébert L. The Montreal
  Cognitive Assessment (MoCA): a Brief Cognitive Screening Tool for Detection of Mild Cognitive Impairment. Presented
  at the 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy.
  http://www.siumed.edu/cme/AlzBrochure04.pdf p. 90, April 14-17, 2004.
• Nasreddine ZS, Collin I, Chertkow H, Phillips N, Bergman H, Whitehead V. Sensitivity and Specificity of The Montreal
  Cognitive Assessment (MoCA) for Detection of Mild Cognitive Deficits. Can J Neurol Sci Volume 30, Number 2
  Supplement 2/May 2003 p 30. Presented at Canadian Congress of Neurological Sciences Meeting, Québec City,
  Québec, June 2003.